CNBC
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Related stories
South China Morning Post
BusinessAug 4, 2026 · 1 min
Is tech the main battleground as EU and US drift apart? One Chinese prediction says so
South China Morning Post
The New York Times
BusinessAug 4, 2026 · 1 min
U.S. Trade Deficit Dips in June as Imports Fall Back
The New York Times
Bloomberg
BusinessAug 4, 2026 · 1 min
US Trade Deficit Narrows to $73.3 Billion as Imports Fall in June
Bloomberg
CNA
BusinessAug 4, 2026 · 1 min
Caterpillar lifts 2026 sales growth forecast as AI buildout powers on
CNA